Navigation Links
Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications
Date:5/19/2008

FORT LAUDERDALE, Fla., May 19 /PRNewswire/ -- Towards the Electronic Patient Record (TEPR) -- IMO, the leader in clinical interface terminology, announced today its next-generation interface terminology delivery service. The service gives clients using IMO-enhanced terminologies access to all of IMO's terminology knowledge sources. The service is powered by terminology searching algorithms optimized for millisecond response times in a highly scalable and redundant environment. The Terminology Portal Service is available for the following IMO products:

-- IMO(R) Problem IT(TM) (mapped to ICD9-CM(1) and SNOMED CT),

-- IMO(R) Procedure IT(TM) (mapped to CPT(R), HCPCS, ICD9 Procedure Codes,

and SNOMED CT),

-- IMO(R) Medication IT(TM) -- (mapped to RxNorm)

"This technology removes three major challenges in the health information market: unreliable search results, managing updates in terminology content, and difficulties with implementation," says Jose Maldonado, IMO's Terminology Product Manager. "With its fast, scalable and predictable search engine, the Terminology Portal Service guarantees reproducible and accurate search results. The hassle-free update mechanism significantly simplifies regulatory updates and change management. The ease of deployment reduces the total cost of ownership."

"Over the past 14 years, we at IMO have consistently observed that a major challenge for EMR/EHR vendors is delivering a consistent and reliable user experience that can accommodate the ever changing healthcare market and diverse user community," says Dr. Andrew S. Kanter, IMO's Chief Medical Officer. "Our portal solution allows our clients to focus on their core business without concerns about the overhead associated with delivering a vocabulary service at the point of care."

Clients of IMO's interface terminology can take full advantage of reference terminologies such as SNOMED CT with minimal development investment
'/>"/>

SOURCE Intelligent Medical Objects, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. OneCommunitys Scot Rourke Named Intelligent Community Visionary of the Year for 2008
2. MSU engineering team designs innovative medical device
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
5. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
6. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
7. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
8. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
9. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
10. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
11. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...1 Milvia Lopez, by her attorney MI...filed suit, in Supreme Court, New York County, bea...at while Ms. Lopez underwent a routine transesopha...ITAL , doctors used an HIV infected scope exposing...veral hours after being discharged from the proced...
(Date:11/21/2009)... based medical credentialing software company Inte... a partnerhsip with Amerinet, Inc., the leading he... help to transform quality care within the healthc...ember 21, 2009 -- ISG Group, LLC, doing business a... with Amerinet Inc., a leading national healthcare...
(Date:11/21/2009)...w Haven Dental Group merges their practice with th... (PRWEB) November 21, 2009...ers Dr. David Gibson, Dr. Dean Cloutier, Dr. John ... their growing practice with that of esteemed coll...decided he wanted to retire from dentistry in orde...
(Date:11/20/2009).... 20 The American Acad...ealth care reform legislation released this week t...urance individual coverage mandate. The actuaries ...l minimize adverse selection stemming from more re... bill. ,, "The individual mandate language shou...
(Date:11/20/2009)... Nov. 20 Rates of infect...ed in late October, but the pandemic flu virus con...age groups, including the elderly, according to a ...: DGX ), the world,s leading provider of diagnos...ts most recent Quest Diagnostics Health Trends(TM)...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...Roche announced today that a total of,20 U.S. and ...eloda(R),(capecitabine) have been accepted for pre...mposium (SABCS) in San AntonioDecember 12-14, incl...cts to be presented at the meeting compare the imp...
... 9 , The following is being issued by Norma... Recently there has been a frenzy of articles in...elivery system. We are told there are 46 million,p...care,rescue plan passed within ninety days of Pres...
... Voonami, Inc., a leading provider of outsourc...nounced today the opening of their first of severa...r in Orem, UT. Voonami also announced two new ada...ty of 300 watts per square foot. , ...
... Despite the recent economic downturn, natural...e industry are still experiencing a wellness boom,...rowth. Natural Healers, the Internet,s top natural... centers to help prospective students interested i...
... Full Spectrum - a leading FDA software develo...h the latest information on code obfuscation techn...able now. , (PRWEB) Decem... the impact of using a basic software engineering ...
...Therapeutics, Inc.,(Nasdaq and MTA: CTIC) announce...ter studies utilizing Zevalin(R) ([90Y]-ibritumoma... of Hematology (ASH) 50th Annual Meeting in,San Fr...initial treatment in,15 patients with advanced sta...
Other Medicine News:Health News:Twenty New Abstracts on Oral Xeloda(R) (capecitabine) Featured at the 31st San Antonio Breast Cancer Symposium 2Health News:Twenty New Abstracts on Oral Xeloda(R) (capecitabine) Featured at the 31st San Antonio Breast Cancer Symposium 3Health News:Average Americans Without Health Insurance Are Young and Healthy With Above Average Incomes 2Health News:Voonami, Inc. Announces Three New Adaptive Data Centers 2Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 2Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 3Health News:Aimed at Medical Device Makers, FDA Software Development Company Full Spectrum Releases Free Technical Report on Software Protection Technology 2Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 2Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 3Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 4Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 5
(Date:11/20/2009)... 20 Soligenix, Inc. (OTC... formerly known as DOR BioPharma, Inc., a late-sta...has formed a consortium to develop thermostable te...ting vaccines. Soligenix received a $9.4 million g...fectious Diseases (NIAID), a division of the Natio...
(Date:11/19/2009)...PRNewswire/ -- In response to an ever-increasing n...medicines, Operation Pangea II, involving 24 count...alth Organization,s International Medical Products...ht the dangers of buying medicines online. ,, T...s of arrests and the seizure of thousands of poten...
(Date:11/19/2009)...Nov. 19 Alexza Pharmaceu... its corporate presentation will be webcast live d...nference on Wednesday, December 2, 2009 at 9:00 a.... from The New York Palace Hotel in New York and wi...t and CEO. ,, To access the live presentation...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics 3A From Concept to Implementation Conference 53480 1Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics 3A From Concept to Implementation Conference 53480 2Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics 3A From Concept to Implementation Conference 53480 3Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 1Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 2Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 3Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 4Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 5Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 1Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 2Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 3Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 4
Symbia T, TruePoint SPECTCT system
Symbia T6, True Point SPECT·CT system
RADIANCE
QUALICHECK+
Medicine Products: